The altered subcellular distribution of ATG9A, as a result of loss-of-functions AP-4 mutation4,69,70, is believed to be a key contributor to the pathology of AP-4 deficiency syndrome4,69–73. Here, ATG9A is linked to hyperinsulinemic hypoglycemia, familial, 4.